Aspergillus peritonitis in a lupus patient on chronic peritoneal dialysis.
A woman on continuous ambulatory peritoneal dialysis (CAPD) due to renal failure in systemic lupus erythematosus (SLE) developed fungal peritonitis and survived following treatment with amphotericin B and removal of the dialysis catheter. The causative organism, Aspergillus fumigatus is very rare in fungal peritonitis and may be related in this case to the combination of SLE, end-stage renal disease (ESRD) and their treatment.
Schattner
Ami
A
Department of Medicine, School of Clinical Medicine, Level 5 Addenbrooke's Hospital, Hills Road, CB2 2QQ, Cambridge, UK. as655@medschl.cam.ac.uk
Kagan
Alexander
A
Zimhony
Oren
O
D000666:Amphotericin B / Q000008:administration & dosage / Q000009:adverse effects; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects; D001228:Aspergillosis / Q000188:drug therapy*; D001232:Aspergillus fumigatus; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000209:etiology* / Q000382:microbiology
D000935:Antifungal Agents; D000666:Amphotericin B